External Funding Opportunities - Page 10
UiO now has set aside 9 million kroner in 2017 for early phase support for innovation projects aimed for a speedy start-up. The deadline is 1 March 2017.
Proposals shall develop and implement a method for the collection of data on bio-based products, taking into consideration the incorporation of the data in the European statistical infrastructure (Eurostat), building on and contributing to on-going activities on exemplary bio-based products (Bio-based Succinic Acid & 1,4-Butandiol, lubricants).
The faculty and Oslo University Hospital are organizing a prequalification process for K.G. Jebsen Centre for Medical Research. The deadline for prequalification applications is 8 February 2017 at 12:00.
A pre-announcement of the ERACoSysMed 2017 Call for proposals has been released: “2nd Joint Transnational Call for European Research Projects on Systems Medicine”. There will be a two-stage submission procedure for joint applications – pre-proposals and full proposals. The call is scheduled to open on February 3rd, 2017.
The LEO Foundation supports international dermatological research projects and activities that address issues in disease understanding, disease treatment, disease awareness and patient wellbeing. Deadlines: several in 2017.
Frontier research often generates unexpected or new opportunities for commercial or societal application. The ERC Proof of Concept Grants aim to maximise the value of the excellent research that the ERC funds, by funding further work to verify the innovation potential of ideas arising from ERC funded projects.
The Research Council is participating in the ERA-NET COFUND EuroNanoMed III joint call for 2017. The call for Norwegian participation is being issued under the NANO2021 programme. There is a two-stage application process.
Innovative training networks bring together universities, research centres and companies from different countries worldwide to train a new generation of researchers.
The funding boosts scientific excellence and business innovation, and enhances researchers’ career prospects through developing their skills in entrepreneurship, creativity and innovation.
Detection and monitoring of cell and tissue transplants in vivo is of utmost importance for development of clinical cell therapy. Suitable nanotechnology-based imaging approaches with high sensitivity should allow for monitoring of cell viability, engraftment and distribution, also through the use of nanomaterials for cells marking. Appropriate imaging techniques have been developed for application in small animals, but are not available yet for use in preclinical large animal models and patients. In particular, such technologies will represent an important safety measure enabling early detection of cell based therapy.
Material concepts based on bio-inspired solutions can also be considered. Modelling of the properties of relevance to manufacturing should be considered and further developed. Although the materials most suited to such development are lightweight advanced composites from different material classes.